Target Audience — Nurse practitioners, nurses and oncology social workers at the intermediate and advanced levels involved in the care of patients with acute lymphoblastic leukemia (ALL).
|Learning Objectives — At the conclusion of this program, participants will be able to:|
|•||Describe the various types and subtypes of acute lymphoblastic leukemia (ALL)|
|•||Identify tests used to diagnose disease and monitor treatment of ALL|
|•||Explain the overarching goals of treatment for the types of ALL|
|•||Explain approved and emerging treatment options for ALL, including stem cell transplantation, and the role of clinical trials|
|•||Describe strategies to manage treatment side effects as well as potential long-term and late effects of treatments for ALL|
Provider — This activity is provided by The Leukemia & Lymphoma Society.
Continuing Education for Nurse Practitioners, Nurses and Social Workers
Nurse Practitioners Credit Designation
This activity is approved for 2.0 contact hour(s) of continuing education (which includes 1.17 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 19073788. This activity was planned in accordance with AANP Accreditation Standards and Policies.
Registered Nursing Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 2.0 continuing education contact hours through the California Board of Registered Nursing.
Social Work Designation
The Leukemia & Lymphoma Society (LLS), Provider Number 1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org. Approved Continuing Education Program (ACE). Approval period: 12/10/2017 – 12/14/2020. LLS maintains responsibility for the program. Social workers should contact their regulatory board to determine course approval. Social workers will receive 2.0 CE clinical contact hours.
The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0117. LLS maintains responsibility for this program. Social workers will receive 2.0 CE clinical contact hours for this activity
Disclosure of Conflicts of Interest
All faculty participating in continuing education activities by The Leukemia & Lymphoma Society are expected to disclose to activity participants any significant financial interest or other relationships with the manufacturer(s) of any commercial product(s) discussed in their presentations. The faculty are also expected to disclose any unlabeled or investigational uses of any product(s) discussed in their presentations.
Ellen K. Richie, MD, has nothing to disclose.
Peter Campbell, PharmD, BCOP , is on the Advisory Board for Insys Therapeutics, Inc.
Lauren Zikind, APN, NP-C, OCN®, has nothing to disclose.
Content Expert Reviewer Disclosure
Lucy M. Holmes, APRN, CNP, MSN, content expert reviewer, has nothing to disclose.
Disclaimer: The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.
Instructions for Credit: There is no fee for this activity. To receive credit for this CE activity, participants must review the accreditation and disclosure information, view the presentation in its entirety, successfully complete the post-activity assessment and evaluation/application for credit. If you do not achieve a minimum score of 70% on the post-activity assessment, you will be allowed to take it again. This course is accredited for up to 2.0 continuing education credits. Please retain a copy of the certificate for your records. For questions regarding the accreditation of this activity, please contact Medical Learning Institute, Inc. at (609) 333-1693 or email@example.com.
|Estimated time to complete activity: 2.0 hours|
|Date of initial release: July 22, 2019|
|Valid for CME credit through: July 22, 2020|
Dr. Ellen K. Ritchie, received her MD from Columbia College of Physicians and Surgeons and trained at New York Presbyterian Hospital at the Columbia College campus. For the last fifteen years, she has been a physician in the Leukemia Program at Weill Cornell Medical College. She is actively engaged in clinical research to find novel agents to treat leukemia, myelodysplastic syndrome and myeloproliferative disorders. She has a strong interest in the treatment of elderly patients and researches clinical interventions that can improve quality of life and outcome in these patients.
Dr. Peter Campbell is an Oncology Clinical Pharmacist at NewYork-Presbyterian Hospital, Columbia University Irving Medical Center in New York, New York. Dr. Campbell’s area of specialized clinical practice is in acute and chronic leukemias, with a primary practice site of the inpatient setting. Dr. Campbell is also the Program Director for the PGY2 Oncology Pharmacy Residency at NewYork-Presbyterian Hospital.Dr. Campbell graduated from St. John’s University College of Pharmacy and Allied Health Professions. He then completed a pharmacy practice residency followed by an oncology pharmacy specialty residency at NewYork-Presbyterian Hospital, and is also a Board Certified Oncology Pharmacist.
Lauren Ziskind, APN, NP-C, OCN® received her undergraduate nursing degree in 2010 and then her family nurse practitioner degree in 2014, both from Resurrection University in Chicago, IL. She has been practicing as a nurse practitioner in the adult leukemia program at the University of Chicago since 2014. She helps care for patients with MPNs, MDS, as well as acute and chronic leukemias in the ambulatory setting. She is involved in several organizations including ISAPN, ONS, AANP, and APSHO. She is passionate about leukemia and all of the recent advancements that have been made treating this illness.
Resources for HCPs
Online & In-person free CME & CE courses: www.LLS.org/CE
Podcast series for healthcare professionals – www.LLS.org/HCPpodcast
Clinical Trials and Research
- Clinical Trials: Learn more about clinical trials: LLS.org/ClinicalTrials
- Research: Focused on finding cures, driving research in areas of unmet medical need, and bridging the gap between academic discovery & drug development: LLS.org/Research
Advocacy dedicated to removing barriers to care: www.LLS.org/Advocacy
Resources for Patients
ALL Specific Resources – www.LLS.org/ALL
Free Information Booklets: www.LLS.org/Booklets
Telephone/Web Education Programs: www.LLS.org/Programs
Support Resources : www.LLS.org/Support
- Financial Assistance
- Travel Assistance
- Referral to Medication Access programs
- Information Resource Center
- LLS Chapters
- LLS Community (social media platform)
- Patti Robinson Kaufman First Connection Program (peer-to-peer)
- One-On-One Nutrition Consultations (PearlPoint)
Information Resource Specialists: www.LLS.org/IRC
Assist through treatment, financial & social challenges, and give accurate treatment and support information. HCPs can also order free materials to distribute to patients.
Clinical Trial Support Center: www.LLS.org/CTSC
Patients & caregivers work one-on-one with clinical trial specialists who are registered nurses with expertise in blood cancers. RNs will personally assist through the clinical trial process, providing an additional resource to your HCP team.
- Phone: (800) 955-4572, M-F, 9 am to 9 pm ET
- Email: infocenter@LLS.org
Live chat: www.LLS.org/InformationSpecialists